Market Overview

Morning Market Losers

Share:
Related ACRX
UPDATE: AcelRX Pharma Says 'We have successfully transitioned ARX-04 into late-stage development, defined the regulatory pathway for ARX-04 and Zalviso in the U.S.'
Earnings Scheduled For March 7, 2016
Related HZNP
Amid Wage Disparities And Political Concerns Over Jobs, Top CEOs Bring In Beaucoup Incomes
Horizon Pharma Reverses Earlier Gains Following Patent Litigation Settlement

AcelRx Pharmaceuticals (NASDAQ: ACRX) fell 33.33% to $7.22 after a blow from the FDA to Zalviso.

Horizon Pharma (NASDAQ: HZNP) shares dipped 31.37% to $9.54 after the company reported that CVS Caremark (NYSE: CVS) and Express Scripts (NASDAQ: ESRX) expect to announce DUEXIS and VIMOVO will no longer be on formularies and will be placed on exclusion lists effective January 1, 2015.

Ceragon Networks (NASDAQ: CRNT) fell 12.86% to $2.10 after the company reported Q2 results and announced a public offering of its ordinary shares.

QAD (NASDAQ: QADB) dropped 7.89% to $15.06. QAD is expected to report FQ2 financial results on August 26, 2014.

Armstrong World Industries (NYSE: AWI) shares declined 7.26% to $51.35 after the company reported weaker-than-expected Q2 results and lowered its FY14 forecast.

The Dixie Group (NASDAQ: DXYN) shares dropped 6.09% to $8.33 after the company reported downbeat Q2 earnings.

Sohu.com (NASDAQ: SOHU) shares fell 2.67% to $55.87 after the company posted a loss in the second quarter. The company posted a quarterly loss of
$45 million, or $1.16 per share, versus a loss of $69 million in the earlier quarter. Non-GAAP net loss came in at US$0.88 loss per share.

Posted-In: market losersNews Movers & Shakers Intraday Update Markets

 

Related Articles (AWI + ACRX)

View Comments and Join the Discussion!